Not Yet Enrolling

A Study of LY3841136 in Japanese Participants With Obesity or Overweight

The main purpose of this study is to learn about the side effects of LY3841136 when given to Japanese participants with obese or overweight.

Trial Summary

Age Range
18 - 65 years
Conditions the trial is for
Obesity
What the trial is testing?
LY3841136
Could I receive a Placebo?
Yes
Enrollment Goal
70
Trial Dates
Apr 5, 2024 - Oct 2025
How long will I be in the trial?
The study will last about 28 weeks and may include up to 17 visits.
Trial Phase
I

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Have overweight or obesity

  • Have had a stable weight for the 3 months before starting the study

Participants Must Not:

  • Have Type 1 or Type 2 diabetes

  • Have or are planning a surgical treatment for weight loss

  • Have been taking or plan to take drugs for weight loss within 3 months prior to starting the study

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Clinical Trial Resources